Coinfection clinical trials

The registry lists 92 studies for Coinfection across more than 10 countries. 12 are recruiting or about to start. 24 of them are mainly about Coinfection (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-17.

Get an email when these change. Save the Coinfection studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 55
Status unknown: 12
Recruiting: 8
Terminated: 7
Withdrawn: 4
Not yet recruiting: 2

Phase

Phase 4: 14
Phase 2: 13
Phase 3: 12
Phase 1: 3
Early Phase 1: 1

Where

United States: 16
China: 8
France: 7
Spain: 7
Thailand: 5
Russian Federation: 4

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (8) · University of Washington (5) · Gilead Sciences (3) · University of Florida (3) · Bayside Health (2) · AbbVie (2) · National Taiwan University Hospital (2) · Xiangya Hospital of Central South University (1)

What is being tested here

Drugs under test in Coinfection studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Interferon gamma-1b	1	1	1
Albendazole	0	0	4
Raltegravir	0	0	3
Praziquantel	0	0	3
Efavirenz	0	0	3
Ribavirin	0	1	3
Dolutegravir	0	1	2
Glecaprevir and pibrentasvir	0	2	2
Tenofovir	0	0	2
Emtricitabine	0	1	2

Drug classes tested here Integrase inhibitors 7 · Reverse transcriptase inhibitors 6

Coming up

1phase 3 study under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Feb 2027Host Immunity, Plasmodium and Pathogens Co-Infections · Institut Pasteur

Who these studies take

Of the 8 Coinfection studies recruiting now, 5 (63%) set no upper age limit and 1 (13%) stop at 75 or younger. 1 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (38%) take healthy volunteers.

Recruiting studies that take each age, of 8
Age	Women	Men
10	1 (13%)	1 (13%)
18	8 (100%)	8 (100%)
30	8 (100%)	8 (100%)
40	8 (100%)	8 (100%)
50	8 (100%)	8 (100%)
65	8 (100%)	8 (100%)
75	7 (88%)	7 (88%)
85	7 (88%)	7 (88%)

Across all 92 studies, recruiting or not: 28% stop at 75 or younger and 24% at 65; 29% take children; 1% are for women only and 1% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 92. Browse all 92 → or search them.